ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Johan F. Vansteenkiste
Paul R. De Leyn
Georges Stalpaert
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vansteenkiste, J. F.
Right arrow Articles by Demedts, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vansteenkiste, J. F.
Right arrow Articles by Demedts, M. G.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1997;63:1441-1450
© 1997 The Society of Thoracic Surgeons


Original Article: General Thoracic

Survival and Prognostic Factors in Resected N2 Non–Small Cell Lung Cancer: A Study of 140 Cases

Johan F. Vansteenkiste, MD, PhD, Paul R. De Leyn, MD, PhD, Georges J. Deneffe, MD, PhD, Georges Stalpaert, PhD, Kris L. Nackaerts, MD, Toni E. Lerut, MD, PhD, Maurits G. Demedts, MD, PhD the Leuven Lung Cancer Group

Departments of Pulmonology (Respiratory Tumor Unit) and Thoracic Surgery, University Hospital Gasthuisberg, Catholic University Leuven, Belgium

Accepted for publication December 13, 1996.

Background. The selection of stage IIIA N2 non–small cell lung cancer patients for primary surgical treatment remains controversial.

Methods. One hundred forty patients with resected non–small cell lung cancer who eventually proved to have pathologic N2 disease were studied with a univariate and multivariate analysis of prognostic factors.

Results. Nineteen patients had a positive mediastinoscopy; the others had a preoperative N0 or N1 stage. Complete resection rate was 80.7%. Five-year survival was 20.8% (95% confidence interval, 17.2% to 24.4%), 32.2% in mediastinoscopy-negative patients. In the univariate analysis, clinical N stage at mediastinoscopy, complete resection, performance status, T stage, number of metastatic levels in adenocarcinoma, and nodal capsule rupture were important factors. In a multivariate model, survival was worse in case of higher T stage (relative risk = 1.43), lower performance status (relative risk = 1.37), involvement of more than one node level (relative risk = 1.68), nonsquamous histology (relative risk = 1.29) and clinical N2 stage (relative risk = 1.43). Long-term survival was unlikely when lactic dehydrogenase or carcinoembryonic antigen levels were elevated.

Conclusions. In clinical N0 or N1 cancer, complete resection resulted in reasonable survival prospects. In patients with N2 disease discovered at mediastinoscopy, surgical treatment was only worthwhile in case of minimal N2. Several unfavorable prognostic factors could be identified in the univariate analysis and confirmed in a multivariate Cox model.


Related Article

Invited Commentary
Robert J. Ginsberg
Ann. Thorac. Surg. 1997 63: 1450. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
L. Spaggiari, A. Tessitore, M. Casiraghi, J. Guarize, P. Solli, A. Borri, R. Gasparri, F. Petrella, P. Maisonneuve, and D. Galetta
Survival After Extended Resection for Mediastinal Advanced Lung Cancer: Lessons Learned on 167 Consecutive Cases
Ann. Thorac. Surg., May 1, 2013; 95(5): 1717 - 1725.
[Abstract] [Full Text] [PDF]


Home page
Acta RadiolHome page
K. Takahashi, T. Sasaki, B. Nabaa, E. J. van Beek, W. Stanford, and T. Aburano
Pulmonary lymphatic drainage to the mediastinum based on computed tomographic observations of the primary complex of pulmonary histoplasmosis
Acta Radiologica, March 1, 2012; 53(2): 161 - 167.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
E. Meacci, A. Cesario, G. Cusumano, F. Lococo, R. D'Angelillo, V. Dall'Armi, S. Margaritora, and P. Granone
Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt
Eur J Cardiothorac Surg, September 1, 2011; 40(3): 656 - 663.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Medical OncologyHome page
T. Berghmans, M. Paesmans, and J.-P. Sculier
Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables
Therapeutic Advances in Medical Oncology, May 1, 2011; 3(3): 127 - 138.
[Abstract] [PDF]


Home page
Eur J Cardiothorac SurgHome page
S. Barnett, J.-M. Baste, K. Murugappan, C. Tog, S. Berlangieri, A. Scott, S. Seevanayagam, and S. Knight
Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging
Eur J Cardiothorac Surg, January 1, 2011; 39(1): 96 - 101.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. S. Kim, H.-S. Lee, J. M. Lee, J. I. Zo, G. K. Lee, and B.-H. Nam
Prognostic value of single nodal zone metastasis in non-small-cell lung cancer
Eur J Cardiothorac Surg, October 1, 2010; 38(4): 491 - 497.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Sakao, S. Okumura, M. Mun, H. Uehara, Y. Ishikawa, and K. Nakagawa
Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases
Ann. Thorac. Surg., April 1, 2010; 89(4): 1060 - 1063.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Friedel, W. Budach, J. Dippon, W. Spengler, S. M. Eschmann, C. Pfannenberg, F. Al-Kamash, T. Walles, H. Aebert, T. Kyriss, et al.
Phase II Trial of a Trimodality Regimen for Stage III Non-Small-Cell Lung Cancer Using Chemotherapy As Induction Treatment With Concurrent Hyperfractionated Chemoradiation With Carboplatin and Paclitaxel Followed by Subsequent Resection: A Single-Center Study
J. Clin. Oncol., February 20, 2010; 28(6): 942 - 948.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
L. Moretti, D. S. Yu, H. Chen, D. P. Carbone, D. H. Johnson, V. L. Keedy, J. B. Putnam Jr., A. B. Sandler, Y. Shyr, and B. Lu
Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy
Oncologist, November 1, 2009; 14(11): 1106 - 1115.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. B. Ratto, R. Costa, P. Maineri, A. Alloisio, P. Bruzzi, and B. Dozin
Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 849 - 858.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
H. Decaluwe, P. De Leyn, J. Vansteenkiste, C. Dooms, D. Van Raemdonck, P. Nafteux, W. Coosemans, and T. Lerut
Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival
Eur J Cardiothorac Surg, September 1, 2009; 36(3): 433 - 439.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Misthos, E. Sepsas, J. Kokotsakis, I. Skottis, and A. Lioulias
The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer
Ann. Thorac. Surg., November 1, 2008; 86(5): 1626 - 1630.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard
Persistent N2 Disease After Induction Therapy Does Not Jeopardize Early and Medium Term Outcomes of Pneumonectomy
Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Dooms, E. Verbeken, S. Stroobants, K. Nackaerts, P. De Leyn, and J. Vansteenkiste
Prognostic Stratification of Stage IIIA-N2 Non-Small-Cell Lung Cancer After Induction Chemotherapy: A Model Based on the Combination of Morphometric-Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography
J. Clin. Oncol., March 1, 2008; 26(7): 1128 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Riquet, P. Bagan, F. Le Pimpec Barthes, E. Banu, F. Scotte, C. Foucault, A. Dujon, and C. Danel
Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases
Ann. Thorac. Surg., December 1, 2007; 84(6): 1818 - 1824.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Nechala, A. J. Graham, S. D. McFadden, S. C. Grondin, and G. Gelfand
Retrospective Analysis of the Clinical Performance of Anterior Mediastinotomy
Ann. Thorac. Surg., December 1, 2006; 82(6): 2004 - 2009.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
T. Okamoto, R. Maruyama, R. Suemitsu, Y. Aoki, H. Wataya, M. Kojo, and Y. Ichinose
Prognostic value of the histological subtype in completely resected non-small cell lung cancer
Interact CardioVasc Thorac Surg, August 1, 2006; 5(4): 362 - 366.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
R. Rami-Porta, M. Mateu-Navarro, J. Freixinet, M. de la Torre, A. Jose Torres-Garcia, Y.-W. Pun, A. Canto Armengod, and on behalf of the Bronchogenic Carcinoma Cooperativ
Type of resection and prognosis in lung cancer. Experience of a multicentre study
Eur J Cardiothorac Surg, October 1, 2005; 28(4): 622 - 628.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
J. Gawrychowski, K. Brulinski, E. Malinowski, and B. Papla
Prognosis and survival after radical resection of primary adenosquamous lung carcinoma
Eur J Cardiothorac Surg, April 1, 2005; 27(4): 686 - 692.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. Berghmans, A. P. Meert, B. Martin, V. Ninane, and J. P. Sculier
Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer
Eur. Respir. J., February 1, 2005; 25(2): 329 - 335.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
N. Lorent, P. De Leyn, Y. Lievens, E. Verbeken, K. Nackaerts, C. Dooms, D. Van Raemdonck, B. Anrys, J. Vansteenkiste, and The Leuven Lung Cancer Group
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
Ann. Onc., November 1, 2004; 15(11): 1645 - 1653.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Oncologist, November 1, 2004; 9(6): 633 - 643.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. M. Keller, M. G. Vangel, H. Wagner, J. H. Schiller, A. Herskovic, R. Komaki, R. S. Marks, M. C. Perry, R. B. Livingston, and D. H. Johnson
Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease
J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 130 - 137.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Inoue, N. Sawabata, S.-i. Takeda, M. Ohta, Y. Ohno, and H. Maeda
Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1100 - 1106.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Venissac, M. Alifano, and J. Mouroux
Video-assisted mediastinoscopy: experience from 240 consecutive cases
Ann. Thorac. Surg., July 1, 2003; 76(1): 208 - 212.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Osaki, K. Sugio, T. Hanagiri, M. Takenoyama, T. Yamashita, M. Sugaya, M. Yasuda, and K. Yasumoto
Survival and prognostic factors of surgically resected T4 non-small cell lung cancer
Ann. Thorac. Surg., June 1, 2003; 75(6): 1745 - 1751.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
M. Tomita, Y. Matsuzaki, M. Edagawa, T. Shimizu, M. Hara, and T. Onitsuka
Lack of prognostic significance of tumor angiogenesis in resected pN2 non-small cell lung cancer
Interact CardioVasc Thorac Surg, June 1, 2003; 2(2): 201 - 205.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. Lardinois, A. Schallberger, D. Betticher, and H.-B. Ris
Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer
Ann. Thorac. Surg., April 1, 2003; 75(4): 1102 - 1106.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
Y. S. Choi, Y. M. Shim, J. Kim, and K. Kim
Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer
Eur J Cardiothorac Surg, November 1, 2002; 22(5): 695 - 700.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. J. Hoekstra, O. S. Hoekstra, S. G. Stroobants, J. Vansteenkiste, J. Nuyts, E. F. Smit, M. Boers, J. W.R. Twisk, and A. A. Lammertsma
Methods to Monitor Response to Chemotherapy in Non-Small Cell Lung Cancer with 18F-FDG PET
J. Nucl. Med., October 1, 2002; 43(10): 1304 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Patelli, L. L. Agli, V. Poletti, R. Trisolini, A. Cancellieri, N. Lacava, F. Falcone, and M. Boaron
Role of fiberscopic transbronchial needle aspiration in the staging of N2 disease due to non-small cell lung cancer
Ann. Thorac. Surg., February 1, 2002; 73(2): 407 - 411.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Deslauriers
Current surgical treatment of nonsmall cell lung cancer 2001
Eur. Respir. J., February 1, 2002; 19(35_suppl): 61S - 70s.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Ishikura, K. Kondo, T. Miyoshi, H. Kinoshita, Y. Takahashi, H. Fujino, and Y. Monden
Suppression of Mediastinal Metastasis by Uracil-Tegafur or cis-Diamminedichloroplatinum(II) Using a Lymphogenous Metastatic Model in a Human Lung Cancer Cell Line
Clin. Cancer Res., December 1, 2001; 7(12): 4202 - 4208.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
L. Voltolini, L. Luzzi, C. Ghiribelli, P. Paladini, M. Di Bisceglie, and G. Gotti
Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy
Eur J Cardiothorac Surg, December 1, 2001; 20(6): 1106 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Ichinose, H. Kato, T. Koike, R. Tsuchiya, T. Fujisawa, N. Shimizu, Y. Watanabe, T. Mitsudomi, M. Yoshimura, and M. Tsuboi
Completely resected stage IIIA non-small cell lung cancer: The significance of primary tumor location and N2 station
J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 803 - 808.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. Andre, D. Grunenwald, J.-P. Pignon, A. Dujon, J. L. Pujol, P. Y. Brichon, L. Brouchet, E. Quoix, V. Westeel, and T. Le Chevalier
Survival of Patients With Resected N2 Non-Small-Cell Lung Cancer: Evidence for a Subclassification and Implications
J. Clin. Oncol., August 16, 2000; 18(16): 2981 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka
PROGNOSIS OF COMPLETELY RESECTED pN2 NON-SMALL CELL LUNG CARCINOMAS: WHAT IS THE SIGNIFICANT NODE THAT AFFECTS SURVIVAL?
J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki
THE PROGNOSIS OF SURGICALLY RESECTED N2 NON-SMALL CELL LUNGCANCER: THE IMPORTANCE OF CLINICAL N STATUS
J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 145 - 153.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
P. De Leyn, J. Vansteenkiste, G. Deneffe, D. Van Raemdonck, W. Coosemans, and T. Lerut
Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy
Eur J Cardiothorac Surg, May 1, 1999; 15(5): 608 - 614.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.